January 2, 2020

Illumina and Pacific Biosciences Announce Termination of Merger Agreement

SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction. Considering the lengthy regulatory approval process the transaction has already been sub


Leave Comment


Your Name *
Your Email *
Your Website

Comment *